Literature DB >> 34251024

Selumetinib for optic pathway glioma: Seeing through the fog, (not yet) the end of the tunnel?

Vijay Ramaswamy1, Ute Bartels1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34251024      PMCID: PMC8485432          DOI: 10.1093/neuonc/noab164

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  11 in total

1.  Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group.

Authors:  Joann L Ater; Tianni Zhou; Emiko Holmes; Claire M Mazewski; Timothy N Booth; David R Freyer; Ken H Lazarus; Roger J Packer; Michael Prados; Richard Sposto; Gilbert Vezina; Jeffrey H Wisoff; Ian F Pollack
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.

Authors:  Jason Fangusaro; Arzu Onar-Thomas; Tina Young Poussaint; Shengjie Wu; Azra H Ligon; Neal Lindeman; Anuradha Banerjee; Roger J Packer; Lindsay B Kilburn; Stewart Goldman; Ian F Pollack; Ibrahim Qaddoumi; Regina I Jakacki; Paul G Fisher; Girish Dhall; Patricia Baxter; Susan G Kreissman; Clinton F Stewart; David T W Jones; Stefan M Pfister; Gilbert Vezina; Jessica S Stern; Ashok Panigrahy; Zoltan Patay; Benita Tamrazi; Jeremy Y Jones; Sofia S Haque; David S Enterline; Soonmee Cha; Michael J Fisher; Laurence Austin Doyle; Malcolm Smith; Ira J Dunkel; Maryam Fouladi
Journal:  Lancet Oncol       Date:  2019-05-28       Impact factor: 41.316

3.  Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study.

Authors:  Sridharan Gururangan; Jason Fangusaro; Tina Young Poussaint; Roger E McLendon; Arzu Onar-Thomas; Shengjie Wu; Roger J Packer; Anu Banerjee; Richard J Gilbertson; Frederic Fahey; Sridhar Vajapeyam; Regina Jakacki; Amar Gajjar; Stewart Goldman; Ian F Pollack; Henry S Friedman; James M Boyett; Maryam Fouladi; Larry E Kun
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

4.  Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.

Authors:  Scott Ryall; Michal Zapotocky; Kohei Fukuoka; Liana Nobre; Ana Guerreiro Stucklin; Julie Bennett; Robert Siddaway; Christopher Li; Sanja Pajovic; Anthony Arnoldo; Paul E Kowalski; Monique Johnson; Javal Sheth; Alvaro Lassaletta; Ruth G Tatevossian; Wilda Orisme; Ibrahim Qaddoumi; Lea F Surrey; Marilyn M Li; Angela J Waanders; Stephen Gilheeney; Marc Rosenblum; Tejus Bale; Derek S Tsang; Normand Laperriere; Abhaya Kulkarni; George M Ibrahim; James Drake; Peter Dirks; Michael D Taylor; James T Rutka; Suzanne Laughlin; Manohar Shroff; Mary Shago; Lili-Naz Hazrati; Colleen D'Arcy; Vijay Ramaswamy; Ute Bartels; Annie Huang; Eric Bouffet; Matthias A Karajannis; Mariarita Santi; David W Ellison; Uri Tabori; Cynthia Hawkins
Journal:  Cancer Cell       Date:  2020-04-13       Impact factor: 31.743

5.  Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study.

Authors:  Alvaro Lassaletta; Katrin Scheinemann; Shayna M Zelcer; Juliette Hukin; Beverley A Wilson; Nada Jabado; Anne Sophie Carret; Lucie Lafay-Cousin; Valerie Larouche; Cynthia E Hawkins; Gregory Russell Pond; Ken Poskitt; Daniel Keene; Donna L Johnston; David D Eisenstat; Rahul Krishnatry; Matthew Mistry; Anthony Arnoldo; Vijay Ramaswamy; Annie Huang; Ute Bartels; Uri Tabori; Eric Bouffet
Journal:  J Clin Oncol       Date:  2016-10-10       Impact factor: 44.544

6.  Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.

Authors:  Rahul Krishnatry; Nataliya Zhukova; Ana S Guerreiro Stucklin; Jason D Pole; Matthew Mistry; Iris Fried; Vijay Ramaswamy; Ute Bartels; Annie Huang; Normand Laperriere; Peter Dirks; Paul C Nathan; Mark Greenberg; David Malkin; Cynthia Hawkins; Pratiti Bandopadhayay; Mark W Kieran; Peter E Manley; Eric Bouffet; Uri Tabori
Journal:  Cancer       Date:  2016-03-10       Impact factor: 6.860

Review 7.  Pediatric low-grade gliomas: next biologically driven steps.

Authors:  David T W Jones; Mark W Kieran; Eric Bouffet; Sanda Alexandrescu; Pratiti Bandopadhayay; Miriam Bornhorst; David Ellison; Jason Fangusaro; Michael J Fisher; Nicholas Foreman; Maryam Fouladi; Darren Hargrave; Cynthia Hawkins; Nada Jabado; Maura Massimino; Sabine Mueller; Giorgio Perilongo; Antoinette Y N Schouten van Meeteren; Uri Tabori; Katherine Warren; Angela J Waanders; David Walker; William Weiss; Olaf Witt; Karen Wright; Yuan Zhu; Daniel C Bowers; Stefan M Pfister; Roger J Packer
Journal:  Neuro Oncol       Date:  2018-01-22       Impact factor: 12.300

8.  A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.

Authors:  Anuradha Banerjee; Regina I Jakacki; Arzu Onar-Thomas; Shengjie Wu; Theodore Nicolaides; Tina Young Poussaint; Jason Fangusaro; Joanna Phillips; Arie Perry; David Turner; Michael Prados; Roger J Packer; Ibrahim Qaddoumi; Sridharan Gururangan; Ian F Pollack; Stewart Goldman; Lawrence A Doyle; Clinton F Stewart; James M Boyett; Larry E Kun; Maryam Fouladi
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

9.  A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.

Authors:  Jason Fangusaro; Arzu Onar-Thomas; Tina Young Poussaint; Shengjie Wu; Azra H Ligon; Neal Lindeman; Olivia Campagne; Anu Banerjee; Sridharan Gururangan; Lindsay B Kilburn; Stewart Goldman; Ibrahim Qaddoumi; Patricia Baxter; Gilbert Vezina; Corey Bregman; Zoltan Patay; Jeremy Y Jones; Clinton F Stewart; Michael J Fisher; Laurence Austin Doyle; Malcolm Smith; Ira J Dunkel; Maryam Fouladi
Journal:  Neuro Oncol       Date:  2021-10-01       Impact factor: 12.300

10.  A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.

Authors:  Sébastien Perreault; Valérie Larouche; Uri Tabori; Cynthia Hawkin; Sarah Lippé; Benjamin Ellezam; Jean-Claude Décarie; Yves Théoret; Marie-Élaine Métras; Serge Sultan; Édith Cantin; Marie-Ève Routhier; Maxime Caru; Geneviève Legault; Éric Bouffet; Lucie Lafay-Cousin; Juliette Hukin; Craig Erker; Nada Jabado
Journal:  BMC Cancer       Date:  2019-12-27       Impact factor: 4.430

View more
  2 in total

Review 1.  Neurosurgery for Optic Pathway Glioma: Optimizing Multidisciplinary Management.

Authors:  Derek C Samples; Jean M Mulcahy Levy; Todd C Hankinson
Journal:  Front Surg       Date:  2022-05-04

2.  A Single-Center Treatment Experience of Gamma Knife Radiosurgery for Optic Pathway Glioma.

Authors:  Youlin Ge; Zhiyuan Zhang; Yanhe Li; Yiguang Lin; Yongqing Zong; Dong Liu
Journal:  Biomed Res Int       Date:  2022-08-09       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.